Clinical Study on Treatment of 50 Cases of Angina Pectosis of Coronary Heart Disease with Skin-Penetrating Administration of Ning Xin Plaster

Hua Haoming~1; Wang Jiaao~2; Yao Zupei~2; et al.

doi:10.13288/j.11-2166/r.2004.11.024

您当前的位置：

首页 >

文章列表页 >

Clinical Study on Treatment of 50 Cases of Angina Pectosis of Coronary Heart Disease with Skin-Penetrating Administration of Ning Xin Plaster

更新时间：2021-11-20

- Clinical Study on Treatment of 50 Cases of Angina Pectosis of Coronary Heart Disease with Skin-Penetrating Administration of Ning Xin Plaster
- Journal of Traditional Chinese Medicine Issue 11, Pages: 834-835(2004)
- 作者机构：
  
  1. 南京中医药大学方剂学教研室
  2. 江苏省南通市中医院
  3. 南京中医药大学附属医院江苏省南京市汉中路282号,210029
- 作者简介：
- 基金信息：
- DOI：10.13288/j.11-2166/r.2004.11.024
  CLC： R259.4
- Published：2004
- 稿件说明：
移动端阅览
[1]华浩明,王家骜,姚祖培,高想,张民庆,李七一.宁心膏透皮给药治疗冠心病心绞痛50例临床研究[J].中医杂志,2004(11):834-835+851.

Hua Haoming~1, Wang Jiaao~2, Yao Zupei~2, et al. Clinical Study on Treatment of 50 Cases of Angina Pectosis of Coronary Heart Disease with Skin-Penetrating Administration of Ning Xin Plaster[J]. Journal of Traditional Chinese Medicine2004, (11): 834-835.
[1]华浩明,王家骜,姚祖培,高想,张民庆,李七一.宁心膏透皮给药治疗冠心病心绞痛50例临床研究[J].中医杂志,2004(11):834-835+851. DOI： 10.13288/j.11-2166/r.2004.11.024.

Hua Haoming~1, Wang Jiaao~2, Yao Zupei~2, et al. Clinical Study on Treatment of 50 Cases of Angina Pectosis of Coronary Heart Disease with Skin-Penetrating Administration of Ning Xin Plaster[J]. Journal of Traditional Chinese Medicine2004, (11): 834-835. DOI： 10.13288/j.11-2166/r.2004.11.024.

摘要

目的:观察宁心膏透皮给药治疗冠心病心绞痛（AP）的临床疗效及其对氧自由基的影响。方法:100例AP患者随机分为常规西药加宁心膏组（治疗组）50例和常规西药加凡士林软膏组（对照组）50例

观察临床疗效.并测定疗程前后血清超氧化物歧化酶（SOD）和过氧化脂质（LPO）。结果:治疗组和对照组的AP疗效总有效率及心电图疗效总有效率分别是92%、63.0%和78%、37.8%（P<0.05或P<0.01）;两组均可提高SOD并降低LPO

但治疗组较对照组为优（P均<0.05）。结论:宁心膏透皮给药能提高中西医结合治疗AP的疗效

提示该药能透皮吸收

扩张冠状动脉

改善心肌缺血及抗氧自由基。

Abstract

Objective: To observe clinical therapeutic effect of skin-penetrating administration ot Ningxin Plaster on angina pectoris of coronary heart disease （AP）and its effects on free radicals. Methods: 100 cases of AP were randomly divided into a treatment group treated by routine western medicine plus Ningxin Plaster （n=50）and a control group treated by routine western medicine plus vaseline（n=50）. Their therapeutic effects were observed. and serum SOD activity and LPO level were determined before and after treatment. Results:The total effective rates for AP and for ECG in the two groups were 92. 0%. 63. 0%

and 78. 0%

37. 8%

respectively （P<0. 05 or P<0. 01）: SOD increased and LPO decreased in the two groups

but the treatment group was superior to the control group （P<0. 05）. Conclusion: Skin-penetrating administration of Ningxin Plaster can increase the therapeutic effect of integrated treatment of Chinese and western medicine. indicating that the drug can be absorbed by penetrating the skin

dilate coronary artery

improve ischemic mayocardium and has the action of anti-free radicals.

关键词

Keywords

references

查看原文

Views

132

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Similarities and Differences between Myofascial Trigger Points and Sinew Knot：from the Perspective of the Channel Sinew Theory

Construction and Application of "Source-Pivot-Convergence" Pattern Identification and Treatment Model for Malignant Tumors

WANG Qingguo's Experience in Treatment of Headache Based on the Concept of "Achieving Harmony by Unblocking and Balancing"

Current Status and Strategic Recommendations for Randomized Controlled Trials on Functional Dyspepsia-Irritable Bowel Syndrome Comorbidity：from a Real-World Research Perspective

Effect of Xiaoqinglong Decoction （小青龙汤） on Th2 Immune Responses and Nasal Mucosal TSLP/OX40L Pathway in Allergic Rhinitis Model Rats

Related Author

No data

Related Institution

No data

Address：No.16, Nanxiao street, Dongzhimen, Dongcheng District, Beijing Postal code：100700
Tel：010-64035632 Email：jtcmcn@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19 京公网安备11010102007558号
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰